Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

iSpecimen Q2 2024 GAAP EPS $(0.19) Beats $(0.28) Estimate, Sales $2.864M Miss $2.881M Estimate

Author: Benzinga Newsdesk | August 06, 2024 06:35am
iSpecimen (NASDAQ:ISPC) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.28) by 32.14 percent. This is a 51.28 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $2.864 million which missed the analyst consensus estimate of $2.881 million by 0.59 percent. This is a 76.25 percent increase over sales of $1.625 million the same period last year.

Posted In: ISPC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist